stella
beta
Low and Intermediate Risk OliGometastatic ColoREctal CancEr PatieNts Treated with Stereotactic ABlative Radiotherapy — Stella
Home
/
Colorectal Cancer
/
Low and Intermediate Risk OliGometastatic ColoREctal CancEr PatieNts Treated with Stereotactic ABlative Radiotherapy
View on ClinicalTrials.gov
Recruiting
Back to Colorectal Cancer trials
Low and Intermediate Risk OliGometastatic ColoREctal CancEr PatieNts Treated with Stereotactic ABlative Radiotherapy
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Italy
IRCCS Sacro Cuore Don Calabria di Negrar, Negrar, Verona